Nearly Double the Biomethane From the Same Biogas: Catator and LTH Students Test the Concept

On-site CO₂ methanation could nearly double a biogas plant’s biomethane output without additional biological feedstock by combining biogas CO₂—which accounts for 40–50% of raw biogas—with renewable hydrogen. The process is described as producing gas with 97–98% methane, and Chemical Engineering students at LTH, Lund University, and Catator are starting a project to test the concept; no test results are reported.

Analysis

The economic bottleneck shifts from access to biogenic feedstock toward the cost and availability of renewable hydrogen and power. That creates an option to raise methane yield from existing plants, but not a free doubling of saleable output: hydrogen production, methanation losses, equipment, and operating requirements determine whether incremental gas earns an adequate return. The strongest use case may be sites with low-cost or curtailed renewable electricity, nearby hydrogen infrastructure, and constrained grid injection—not the average biomethane plant.

For incumbent operators, successful integration could improve output per unit of digester capacity and make existing sites more valuable. Conversely, electrolyzer and renewable-power developers may capture much of the economics; direct electrification and other hydrogen users remain competing demand. Catator’s student-linked project is an early technical signal, not evidence of commercial uptime, cost competitiveness, or a bankable revenue stream. Over 1–3 months, policy eligibility and project performance data matter more than the concept; over 6–18 months, repeat orders and operating economics would be needed to support a structural re-rating. No identifiable listed-company exposure or investable catalyst is supplied here.

Key Decisions for Investors

• No immediate event-driven position. Treat this as a technology watch item rather than evidence to upgrade the biomethane sector.
• If the project advances, verify hydrogen consumption per unit of methane, parasitic power, uptime, catalyst life, installed cost, and whether the resulting gas qualifies for relevant EU support. These determine whether incremental output translates into cash flow.
• A conditional relative-value screen: favor biomethane operators with access to low-cost renewable power and existing gas infrastructure over feedstock-constrained developers only if disclosed project economics show attractive returns; avoid broad exposure based on output claims alone.
• Falsifiers for the bullish pathway are poor operating availability, hydrogen costs that erase the value of added gas, or regulatory treatment that excludes the pathway from relevant incentives. A repeatable commercial installation and independently verifiable operating data would strengthen it.